Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Prosetta
AddedFeb 15, 2024
UpdatedJun 18, 2026
Prosetta

Prosetta

Series D

Prosetta Biosciences: A US-based biotech firm specializing in drug discovery and development.

HQ
San Francisco, CA, US
Founded
2013
Overview
Compare
Fundraising
Employees
Website

Prosetta Biosciences, founded in San Francisco, is a biotechnology company dedicated to drug discovery and development. The company's core mission is to create innovative therapeutics for various diseases by identifying and advancing novel small molecules that modulate the assembly of multi-protein complexes within cells. Prosetta offers a range of programs, including antiviral, antibacterial, neuroscience, oncology, and exploratory applications, primarily targeting the US market.

Notable figures associated with Prosetta include leading scientists and industry experts in biotechnology and pharmaceuticals. The company has garnered attention for its significant achievements, such as developing a viral assembly inhibitor that blocks SARS-CoV-2 replication in airway epithelial cells. Prosetta's work has had a substantial impact on the field of drug discovery, contributing to advancements in therapeutic solutions for critical diseases.

Prosetta - Similar Companies

Proteotech logo

Proteotech

ProThera Biologics logo

ProThera Biologics

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

ProteoNova logo

ProteoNova

proteonova.com

Proterixbio logo

Proterixbio

Scribe Biosciences logo

Scribe Biosciences

Protea Biosciences logo

Protea Biosciences

proteabio.com

Seven Biosciences logo

Seven Biosciences

PathDrugomics logo

PathDrugomics

BridGene Biosciences logo

BridGene Biosciences

Viscient Bio logo

Viscient Bio

Terremoto Biosciences logo

Terremoto Biosciences

terremotobio.com

Kezar Life Sciences logo

Kezar Life Sciences

NantBio logo

NantBio

PhenoVista Biosciences logo

PhenoVista Biosciences

phenovista.com

Prosetta - Quick Facts

Who are Prosetta's competitors?

Companies similar to Prosetta include Proteotech, ProThera Biologics, ProFound Therapeutics and ProteoNova.

When was Prosetta founded?

Prosetta was founded in 2013.

Where is Prosetta's headquarters located?

Prosetta's headquarters is located in San Francisco, CA, US.

When was Prosetta's last funding round?

Prosetta's most recent funding round was for $31M (USD) in December 2015.

How much has Prosetta raised to-date?

As of Dec 3, 2015, Prosetta has raised a total of $33M (USD).

How many employees does Prosetta have?

Prosetta has 29 employees as of Feb 5, 2024.

Prosetta - Classification

Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
ISIC
  • 7210Research and experimental development on natural sciences and engineering
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
  • 541715Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified